Explorer les evidences

7 %A review and meta-analysis study of COVID-19 patients in April 2020 revealed bacterial co-infections in 7% of hospitalized patients.

NigeriaCOVID-19observé April 2020HAL · Unilimdocument de 63 observations

7,15 daysThe mean recovery time from symptom onset was 7.15 days for COVID-19 patients treated with ivermectin.

NigeriaCOVID-19publié 2022West African journal of medicinePubMeddocument de 2 observations

50 %More than 50% of mild and moderate COVID-19 cases received antimicrobial prescription.

NigeriaCOVID-19HAL · Unilimdocument de 63 observations

22,2 %Moderna was the second most administered COVID-19 vaccine, accounting for 22.2% of doses.

NigeriaCOVID-19observé April-June 2024publié 2026Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument de 8 observations

9,07 per_1000_person_daysThe mortality rate was 9.07 per thousand person-days among patients with COVID-19 admitted to a tertiary referral hospital in Lagos, Nigeria.

NigeriaCOVID-19publié 2023Nigerian journal of clinical practicePubMeddocument de 6 observations

95 %95% of the participants believed SARS-CoV-2 infection is a viral infection.

NigeriaCOVID-19publié 2022Nigerian journal of clinical practicePubMeddocument de 9 observations

67,5 %Among RT-PCR-negative patients, 67.5% were symptomatic, compared to 44.6% among RT-PCR-positive patients.

NigeriaCOVID-19observé 27 February 2020 to 30 September 2020publié 2021The Nigerian postgraduate medical journalPubMeddocument de 12 observations

33,7 %Cough was present in 33.7% of RT-PCR-negative patients and 23.1% of RT-PCR-positive patients.

NigeriaCOVID-19observé 27 February 2020 to 30 September 2020publié 2021The Nigerian postgraduate medical journalPubMeddocument de 12 observations

0,43 aORUse of a face mask was associated with decreased odds of SARS-CoV-2 infection (adjusted odds ratio 0.43, 95% CI: 0.19–0.95).

NigeriaCOVID-19observé April to July 2020publié 2022The Pan African medical journalPubMeddocument de 13 observations